Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter
Recall from a federal regulator
Headline as published by U.S. Food and Drug Administration (Recalls) on Sep 18, 2026; collected by the wire Oct 1, 2026, 7:45 PM ET.
ROCHESTER, MI– September 18, 2026 –Par Health is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose or stopper materia
Coverage
Topics
- Recalls and safety alertsMatched on
Recall
Explore the named firms, organizations and MDL dockets above. Sources and method